Asked by: Apsana Begum (Labour - Poplar and Limehouse)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how many Prevention of Future Deaths Reports have related to (a) universal credit and (b) other benefits in each of the last five years.
Answered by Paul Maynard - Parliamentary Under-Secretary (Department for Work and Pensions)
The Department has received 6 Prevention of Future Death (PFD) reports in the last five years to date. 1 report did not relate to a customer who was in receipt of benefits. The breakdown of the reports by year and the benefit claimed is provided in the table below:
Number of PFD reports received in the last 5 years | Universal Credit (UC) | Personal Independence Payment (PIP) | Employment and Support Allowance (ESA) and PIP | Not in Receipt of Benefits |
2020 | 0 | 0 | 0 | 0 |
2021 | 1 | 1 | 0 | 1* |
2022 | 0 | 0 | 0 | 0 |
2023 | 1 | 0 | 1 | 0 |
2024 | 1 | 0 | 0 | 0 |
* This report related to Child Maintenance.
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether there are contracts for the cremation of (a) stillborns, (b) miscarriages and (c) baby deaths at a (i) national and (ii) NHS trust level; and if she will publish (A) details and (B) the start dates of those contracts.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Neither the Department nor NHS England holds information on contracts for the cremation of stillborns, miscarriages, and baby deaths.
Asked by: Caroline Lucas (Green Party - Brighton, Pavilion)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department is collating data from toxicology reports of non-fatal overdose incidents to assess the risk from synthetic opioids.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is undertaking a number of actions to address the risk that synthetic opioids pose. The Department has a longstanding surveillance system in place to collect information on the nature and location of novel drug use, drug markets, and reports alerting us to drug harms experienced. We continue to monitor the threat posed by synthetic opioids, and are working to improve drug surveillance on synthetic opioids through the development of an early warning system. This will include, with the permission of coroners, toxicology results for fatal overdose cases from across England as soon as the information is available, enabling the Department to closely monitor the substances causing deaths.
We know that most overdoses take place when individuals are alone, or accompanied by others also using drugs. This means they are largely transitory and hidden events, with no opportunity for sampling. A key indicator, therefore, is those who do come into contact with first responders, who are administered the lifesaving opioid reversal drug naloxone, or who are admitted to hospital. Ambulance data represents an opportunity for rapidly identifying local spikes in overdoses and, for this purpose, we are establishing data feeds with ambulance trusts in England, on callouts where naloxone has been administered.
Asked by: Neale Hanvey (Alba Party - Kirkcaldy and Cowdenbeath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her policies of the article in the British Medical Journal entitled Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds, published on 27 May 2021; and if she will have discussions with the Medicines and Healthcare products Regulatory Agency on the contents of the report.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Following the initial roll out of the COVID-19 vaccination programme in December 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) had a comprehensive surveillance strategy in place, enabling continual close monitoring of emerging safety evidence including studies, published literature, and data arising from the widespread use in the United Kingdom and globally. This included the article and Norwegian reports highlighted. The MHRA communicates safety advice based upon consideration of the totality of evidence from all relevant information sources, rather than the strengths and limitations of individual data sources.
Asked by: Earl of Sandwich (Crossbench - Excepted Hereditary)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what explanation they have received from the Sudanese authorities for an air strike on a school in South Kordofan state on 14 March, which resulted in the deaths of 11 children and two teachers and multiple injuries.
Answered by Lord Benyon - Minister of State (Foreign, Commonwealth and Development Office)
Our senior diplomats have used meetings with senior decision-makers in the Sudanese Armed Forces (SAF), Rapid Support Forces (RSF) and other groups to raise concerns about credible reports of human rights violations. The UK continues to urge the warring parties to agree to a ceasefire, engage in a meaningful peace process, and grant immediate humanitarian access. The UK is also funding open-source investigation experts to use satellite imagery and social media to verify and preserve information relating to attacks against civilians and civilian infrastructure. It is essential that those responsible for human rights violations and abuses are held to account.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to her Department's press release entitled £5 million fund to tackle fatal drug deaths across the UK, published on 29 August 2023, how this funding will be distributed; and what criteria her Department is using to select projects for this funding.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
As part of the Reducing Drug Deaths Innovation Challenge, which aims to reduce drug-related deaths across the United Kingdom, the Department is investing in 12 projects to develop technologies aimed at improving detection, response, or intervention in potential drug-related deaths.
Applicants submitted proposals, and these were assessed by an independent panel. Detailed assessment criteria were worked up by NHS Fife, and then moderated before awards were made. They included how well the project met the challenge described in the competition scope, the main technical challenges addressed, what similar products were available and how the proposal differentiated from them, project plan and milestones, expertise, cost, and commercial potential. We awarded funding to 12 projects, with further information available at the following link:
https://www.gov.uk/government/news/5-million-fund-to-tackle-fatal-drug-deaths-across-the-uk
This funding supports wider Government initiatives to tackle drug misuse in society. The UK’s drugs strategy, published in December 2021, has a key objective to prevent 1,000 drug deaths in England by 2025. This aligns with work within and across the four nations of the UK to improve systems of support and reduce drug-related deaths.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Cabinet Office:
To ask the Minister for the Cabinet Office, what estimate she has made of the number of illegal drug related deaths in (a) Romford constituency and (b) England.
Answered by John Glen - Paymaster General and Minister for the Cabinet Office
The information requested falls under the remit of the UK Statistics Authority.
A response to the Hon gentleman Parliamentary Question of 21st March is attached.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she has taken to support (a) research into and (b) treatment of heart disease in (i) England and (ii) Romford constituency.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department supports research through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including those relating to heart disease. Over the past five financial years, the NIHR has spent over £64 million on heart-disease related research projects. In addition, the NIHR infrastructure provides clinical expertise, specialist facilities, workforce, and support services to support research across a range of clinical areas, including heart disease.
The Be Part of Research campaign makes it easier for people to find out about, and take part in, health and care research. Currently, there are seven high quality studies related to heart and circulation, which are being supported by the NIHR and are within five miles of Romford.
The NHS Long Term Plan sets out that by 2028 the proportion of patients accessing cardiac rehabilitation will be amongst the best in Europe, with up to 85% of those eligible accessing care. This will prevent up to 23,000 premature deaths and 50,000 acute admissions over 10 years. The NHS Health Check programme is a core component of England's cardiovascular diseases prevention pathway. Over 15 million people are eligible for an NHS Health Check every five years, and it delivers 1.3 million checks a year, preventing an estimated 500 heart attacks and strokes.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will publish the Regulatory Policy Committee's original opinion on the Tobacco and Vapes Bill submitted to her Department on 12 February 2024; if she will outline the changes she has made to that Bill since receiving that opinion; and what discussions she has had with the Regulatory Policy Committee on the expected timetable for their submission of the revised opinion.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:
https://bills.parliament.uk/bills/3703
On 12 February 2024 the Regulatory Policy Committee (RPC) gave opinion on the Tobacco and Vapes Bill impact assessment and rated it green (fit for purpose). However, on 19 March 2024, ahead of the introduction of the bill, a revised version was sent to the RPC for comment. This included changes to reflect the inclusion of Northern Ireland in the bill, following the formation of a Northern Ireland Executive, and a power in the bill to enable the current notification system for nicotine vapes to also cover non-nicotine vapes and other consumer nicotine products, for instance nicotine pouches. The RPC have publicly stated that they welcome the resubmission of the revised impact assessment, and we expect a revised opinion to be issued shortly. The statement from the RPC is available at the following link:
https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that the Regulatory Policy Committee's revised opinion on the Tobacco and Vapes Bill is published by 16 April 2024.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Smoking is responsible for approximately 80,000 deaths a year in the United Kingdom, and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year, and puts a huge burden on the National Health Service. That is why we have introduced the Tobacco and Vapes Bill to create the first smokefree generation, and enable us to further crack down on youth vaping. The Tobacco and Vapes Bill is available at the following link:
https://bills.parliament.uk/bills/3703
On 12 February 2024 the Regulatory Policy Committee (RPC) gave opinion on the Tobacco and Vapes Bill impact assessment and rated it green (fit for purpose). However, on 19 March 2024, ahead of the introduction of the bill, a revised version was sent to the RPC for comment. This included changes to reflect the inclusion of Northern Ireland in the bill, following the formation of a Northern Ireland Executive, and a power in the bill to enable the current notification system for nicotine vapes to also cover non-nicotine vapes and other consumer nicotine products, for instance nicotine pouches. The RPC have publicly stated that they welcome the resubmission of the revised impact assessment, and we expect a revised opinion to be issued shortly. The statement from the RPC is available at the following link:
https://www.gov.uk/government/news/the-tobacco-and-vapes-bill-statement-from-the-rpc